| ²é¿´: 1732 | »Ø¸´: 15 | |||||||||||||||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||||||||||||||
sundiaгæ (³õÈëÎÄ̳)
|
[½»Á÷]
É£µÏÑÇÒ½Ò©¼¼Êõ £¨ÉϺ££©ÓÐÏÞÔðÈι«Ë¾ ³ÏÕÐÓ¢²Å
|
||||||||||||||||
É£µÏÑÇÒ½Ò©¼¼Êõ £¨ÉϺ££©ÓÐÏÞÔðÈι«Ë¾ ÕÐÆ¸ÐÅÏ¢ Founded by a group of veterans from US biopharmaceutical industries in 2004, Sundia MediTech Company Ltd. Is now a leading Shanghai-based pharmaceutical biotech R&D out-sourcing company. Recently merged with United PharmaTech formed alliance with HD Biosciences, Sundia offers broad integrated services of custom organic synthesis, medicinal chemistry, process chemistry, APIs manufacturing under cGMP or non-cGMP, bioassay, in vitro & in vivo PK studies. We have successfully established collaborations with over 60 client companies in North America, Europe, Japan. Our professional team possesses talents from organic synthesis, medicinal chemistry, process chemistry, biology, to business management, law. Sundias management team members have received advanced degrees or training have extensive working / management experiences in North America. Our research team comprises over 300 scientists, among which 18% are Ph.D.s 57% MSs 25% BSs. É£µÏÑÇÒ½Ò©¼¯ÍŰüÀ¨Èý¸öÈ«×Ê×Ó¹«Ë¾£¬¼´¾ùΪÍâÉ̶À×ÊÆóÒµ£¬×¢²á×ʱ¾8000ÍòÔªÈËÃñ±Ò£¬ÓÚ2004Äê6ÔÂ8ÈÕÕýʽÔËÓª¡£Ö÷ÓªÒµÎñ°üÀ¨Ò½Ò©Ñз¢ºÍÖÆÔì¡£ ¹«Ë¾µÄ¹ÜÀíÈËÔ±£¬´ÓCEOµ½¸÷²¿ÃÅÖ÷¹Ü£¬È«¶¼À´×Ô¹úÄÚÍâ¸÷רҵÁìÓòÄÚµÄÒ»Á÷ר¼Ò£¬°üÀ¨ºÏ³É»¯Ñ§¡¢Ò©Îﻯѧ¡¢Ò©ÎïÉè¼Æ¡¢Ò©´ú¶¯Á¦Ñ§¡¢¹¤ÒÕ»¯Ñ§¡¢ÖƼÁÑз¢¡¢·ÖÎö·þÎñ¡¢GMP¸ßЧÔÁÏÒ©ÑÐÖÆ¡¢ÆóÒµ¹ÜÀíµÈ¡£ ¹«Ë¾ÔÚÆÖ¶«ÕŽ¸ß¿Æ¼¼Ô°Çø¡£ÓµÓÐÕ¼µØÃæ»ýÔ¼15000ƽ·½Ã׵ĿÆÑÐÖÐÐÄ£¬×°±¸ÁËÊÀ½çÒ»Á÷µÄ¿ÆÑÐÒÇÆ÷£¬°üÀ¨ÒºÏàÉ«Æ×-ÖÊÆ×ÁªÓÃÒÇ£¨Agilent 1100 LC-Finnigan MSD£©¡¢ÖƱ¸Ð͸ßЧҺÏàÉ«Æ×ÒÇ£¨Gilson£©¡¢Î¢²¨ºÏ³ÉÒǵȳÉÌ×ÏȽøÉ豸£¬²¢×Ô¹ºÁËÁª»ú»¯Ñ§ÎÄÏ׿â¼ìË÷£¨Crossfire£©£¬»¯Ñ§ºÍÉúÎïÐÅÏ¢Êý¾Ý¹ÜÀíϵͳCBISÈí¼þ£¨ChemInnovation, USA£©£¬Îª¹«Ë¾µÄ¿ÆÑз¢Õ¹ÌṩÁËÇ¿´óµÄÓ²¼þºÍÈí¼þ±£Ö¤¡£ ¹«Ë¾ÓµÓжÀÌØµÄÆóÒµÎÄ»¯£¬¹ÄÀøÔ±¹¤µÄ¸÷ÖÖ´´ÐÂ˼Ï룬³«µ¼¹«Ë¾ÄÚÍâµÄѧÊõ½»Á÷£¬¹ÄÀø×Ô϶øÉϵÄÅúÆÀÒâ¼û¡£¹«Ë¾³ÐÈÏѧÀú£¬µ«¸üÖØÊÓÔ±¹¤µÄʵ¼Ê±íÏÖ£¬¹«Ë¾ÉèÁ¢µÄÔ¹⽱¡¢Ñô¹â½±¡¢×êʯ½±½±Àø¶Ô¹«Ë¾ÓÐÖØ´óÍ»³ö¹±Ï×µÄÔ±¹¤¡£¹«Ë¾Òª ÿ¸öÔ±¹¤¾ßÓмè¿à´´ÒµµÄÏ×Éí¾«Éñ¡¢ÑϸñµÄ¼ÍÂɺͽôÃÜÅäºÏµÄÍŶÓ×÷·ç£¬¹«Ë¾Í¬Ê±Ò²¸øÃ¿¸öÔ±¹¤´´Ôì¿íËÉ»îÆÃ¡¢Ç×ÃÜÎÞ¼äµÄ¹¤×÷»·¾³¡£¹«Ë¾ÒѾʵʩÁËÔ±¹¤³Ö¹É¼Æ»®¡£ÎÒÃǵÄÄ¿±êÊÇ£¬ÔÚ½¨Á¢¾ßÓÐ×ÔÖ÷Ñз¢ÄÜÁ¦ºÍ֪ʶ²úȨµÄÖÆÒ©¹«Ë¾µÄͬʱ£¬ÊµÏÖÿ¸öÔ±¹¤µÄÈËÉú¼ÛÖµ£¡ Ëæ×Ź«Ë¾ÒµÎñµÄ²»¶Ï·¢Õ¹£¬ÏÖ¹«Ë¾ÓÐÒÔÏÂְλÐèÒª¹«¿ªÕÐÆ¸£¬Ó¦Æ¸Õß¿ÉÑ¡ÔñÔÚÍøÉÏͶµÝ¼òÀú£¨Çë²»ÒªÒÔ¸½¼þÐÎʽ£©£¬Ò²¿ÉÑ¡ÔñÓʼļòÀú»ò´«Õæ¼òÀú¡£ »¯Ñ§ºÏ³ÉÑо¿ÈËÔ± ÒªÇ󣺱¾¿Æ¼°ÒÔÉÏÓлú»¯Ñ§¡¢Ò©ÎﻯѧµÈÏà¹Ø×¨Òµ£¬ÓÐÎÞ¹¤×÷¾Ñ飬Íù½ìÓ¦½ì¾ù¿É¡£ ÓÉÃæÊÔÖ®ºó¾ö¶¨£¬¾ßÌåµ£ÈκÎÖÖְλ¡£ ÓÊÏ䣺hr@sundia.com ¹«Ë¾Ö÷Ò³£ºwww.sundia.com |
» ²ÂÄãϲ»¶
302Çóµ÷¼ÁÒ»Ö¾Ô¸»ªÖÐʦ·¶´óѧ
ÒѾÓÐ4È˻ظ´
288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤
ÒѾÓÐ32È˻ظ´
Ò»Ö¾Ô¸Ö£´ó²ÄÁϹ¤³Ì290Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
»·¾³¹¤³Ì297·ÖÇóµ÷¼ÁÒ»Ö¾Ô¸º¼¸ßÔº
ÒѾÓÐ12È˻ظ´
366Çóµ÷¼ÁÒ»Ö¾Ô¸¶«±±´óѧ
ÒѾÓÐ7È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁÏÓ뻯¹¤306·ÖÕÒµ÷¼Á
ÒѾÓÐ5È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
w20073201
ľ³æ (ÕýʽдÊÖ)
СÃÛ·ä
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 2861.4
- É¢½ð: 31
- Ìû×Ó: 372
- ÔÚÏß: 354.4Сʱ
- ³æºÅ: 793821
- ×¢²á: 2009-06-13
- ÐÔ±ð: MM
- רҵ: ÖÐҩѧÆäËû¿ÆÑ§ÎÊÌâ

5Â¥2011-04-15 22:22:10
Mickey_ing
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 3974.8
- É¢½ð: 504
- ºì»¨: 1
- ɳ·¢: 7
- Ìû×Ó: 418
- ÔÚÏß: 165.5Сʱ
- ³æºÅ: 1132402
- ×¢²á: 2010-10-26
- ÐÔ±ð: GG
- רҵ: »¯¹¤ÏµÍ³¹¤³Ì

4Â¥2011-04-15 20:53:19
| ¶¥~ |
6Â¥2011-04-25 10:01:40
oliver212
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 691.3
- ºì»¨: 2
- Ìû×Ó: 104
- ÔÚÏß: 74.1Сʱ
- ³æºÅ: 718869
- ×¢²á: 2009-03-09
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É

9Â¥2011-04-26 20:06:42














»Ø¸´´ËÂ¥
±¾¿ÆÓÐÒ»Ä깤×÷¾ÑéµÄ´ýÓöÒ»°ã¶àÉÙ